India's Pharmaceutical Exports

Country Profile

Latvia

Latvia is a growing market for Indian pharmaceuticals — $171M in FY 2025–26, with 9.4× growth over the past decade. Medicines accounts for 97% of shipments, with vaccines contributing $589K. The compound annual growth rate since FY2015 stands at 22.6%.

🇱🇻 $171M · 9.4× growth since FY2015 · 22.6% CAGR
Single-source profile. All data from DGCIS India export records (fiscal year, April–March).
$171M
Exports FY2025–26 DGCIS
9.4×
Growth FY2015→2026
22.6%
CAGR FY2015→2026
97%
Medicines Share
5
Product Categories Supplied
Latvia is a growing market for Indian pharmaceuticals — $171M in FY 2025–26, with 9.4× growth over the past decade. Medicines accounts for 97% of shipments, with vaccines contributing $589K. The compound annual growth rate since FY2015 stands at 22.6%.
Export Trend DGCIS FY
Category Mix — FY 2025–26 DGCIS
Medicines $166M (97.1%) Surgical & Hospital Supplies $2.37M (1.4%) Traditional & Herbal $1.44M (0.8%) Vaccines $589K (0.3%) Medicine Ingredients $586K (0.3%)
Top 10 Products — FY 2025–26 DGCIS
Indian Pharma Investment Source: RBI ODI Data

No recorded pharmaceutical sector investment transactions from Indian companies to Latvia in the RBI overseas direct investment dataset (2011–2026).